{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:30:01Z","timestamp":1787725801462,"version":"build-2784847793"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this work is to examine whether the early addition of vitamin A\/D drops to caffeine citrate was associated with bronchopulmonary dysplasia (BPD) and short-term respiratory outcomes in preterm infants born at &amp;lt;32 weeks\u2019 gestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center, 72-h landmark retrospective cohort study included 126 infants admitted to the hospital between October 2022 and November 2024 with a gestational age &amp;lt;32\u2005weeks and birth weight \u22641.5\u2005kg. Exposure was determined at 72\u2005h as either caffeine alone or caffeine plus vitamin A\/D drops. Complete-case analyses were performed. Among the 119 infants who survived to 36\u2005weeks\u2019 postmenstrual age, BPD, longitudinal outcomes, and clinical course were evaluated. Multivariable regression and stabilized inverse probability of treatment weighting (IPTW) were applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>BPD occurred in 20 of 55 survivors (36.4%) receiving caffeine alone and 11 of 64 (17.2%) receiving combination therapy. After adjustment for gestational age, birth weight, and grade III\u2013IV respiratory distress syndrome, combination therapy was associated with a lower risk of BPD [adjusted odds ratio (aOR), 0.36; 95% confidence interval (CI), 0.14\u20130.90]. The composite outcome of death or BPD occurred in 25 of 60 infants (41.7%) in the caffeine group and 13 of 66 (19.7%) in the combination group (extended-model aOR, 0.33; 95% CI, 0.14\u20130.80); IPTW results were consistent. Combination therapy was also associated with more favorable changes in blood gas and inflammatory markers, along with shorter durations of respiratory support and hospitalization. No serious adverse event required permanent treatment discontinuation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among infants who survived to 72\u2005h, early initiation of vitamin A\/D drops as an adjunct to caffeine was associated with lower risks of BPD and death or BPD, as well as more favorable short-term respiratory outcomes. Non-randomized treatment allocation, complete-case selection, and residual confounding preclude causal inference.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1923440","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:57:21Z","timestamp":1787723841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of caffeine citrate plus vitamin A\/D drops with bronchopulmonary dysplasia and respiratory outcomes in preterm infants born at &lt;32\u2005weeks\u2019 gestation: a 72-h landmark retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Rongying","family":"Su","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Shijiazhuang People\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohua","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shijiazhuang People\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","article-title":"The diagnosis of bronchopulmonary dysplasia in very preterm infants: an evidence-based approach","volume":"200","author":"Jensen","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"L832","DOI":"10.1152\/ajplung.00369.2019","article-title":"Recent advances in our understanding of the mechanisms of lung alveolarization and bronchopulmonary dysplasia","volume":"317","author":"Lignelli","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s12098-021-03766-w","article-title":"Recent advances in bronchopulmonary dysplasia","volume":"88","author":"Shukla","year":"2021","journal-title":"Indian J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1038\/s41372-021-01095-6","article-title":"New BPD-prevalence and risk factors for bronchopulmonary dysplasia\/mortality in extremely low gestational age infants \u226428 weeks","volume":"41","author":"Geetha","year":"2021","journal-title":"J Perinatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jpeds.2018.01.043","article-title":"Bronchopulmonary dysplasia: executive summary of a workshop","volume":"197","author":"Higgins","year":"2018","journal-title":"J Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41390-022-02451-8","article-title":"Bronchopulmonary dysplasia prediction models: a systematic review and meta-analysis with validation","volume":"94","author":"Kwok","year":"2023","journal-title":"Pediatr Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine for apnea of prematurity trial group. Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Caffeine for apnea of prematurity trial group. Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41372-024-01939-x","article-title":"Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis","volume":"44","author":"Oliphant","year":"2024","journal-title":"J Perinatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/s41372-021-01172-w","article-title":"Caffeine citrate for apnea of prematurity-one dose does not fit all: a prospective study","volume":"41","author":"Rosen","year":"2021","journal-title":"J Perinatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.clp.2021.08.006","article-title":"Lung protection during mechanical ventilation in the premature infant","volume":"48","author":"Williams","year":"2021","journal-title":"Clin Perinatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1056\/NEJM199906243402505","article-title":"Vitamin A supplementation for extremely-low-birth-weight infants","volume":"340","author":"Tyson","year":"1999","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0265876","DOI":"10.1371\/journal.pone.0265876","article-title":"Oral vitamin A supplementation in preterm infants to improve health outcomes: a systematic review and meta-analysis","volume":"17","author":"Phattraprayoon","year":"2022","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S2213-2600(24)00073-0","article-title":"Neovitaa trial investigators. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial","volume":"12","author":"Meyer","year":"2024","journal-title":"Lancet Respir Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1097\/MS9.0000000000003452","article-title":"Enteral vitamin A supplementation for the prevention of bronchopulmonary dysplasia in preterm infants: an updated systematic review and meta-analysis","volume":"87","author":"Rustam","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0235332","DOI":"10.1371\/journal.pone.0235332","article-title":"Association between vitamin D level and bronchopulmonary dysplasia: a systematic review and meta-analysis","volume":"15","author":"Park","year":"2020","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e28088","DOI":"10.1097\/MD.0000000000027966","article-title":"Association between vitamin D deficiency at one month of age and bronchopulmonary dysplasia","volume":"100","author":"Byun","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.34172\/aim.2022.06","article-title":"Association between vitamin D insufficiency and respiratory problems in premature neonates","volume":"25","author":"Jafari","year":"2022","journal-title":"Arch Iran Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/ppul.25813","article-title":"Effects of early vitamin D supplementation on the prevention of bronchopulmonary dysplasia in preterm infants","volume":"57","author":"Ge","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2174\/0115733963279420240402083916","article-title":"Effects of vitamin D and E supplementation on prevention of bronchopulmonary dysplasia in premature neonates: a systematic review and meta-analysis","volume":"21","author":"Farahbakhsh","year":"2025","journal-title":"Curr Pediatr Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e48956","DOI":"10.1097\/MD.0000000000048956","article-title":"Clinical efficacy of different supplemental doses of vitamins A and D in preventing bronchopulmonary dysplasia in preterm infants: a network meta-analysis based on randomized controlled trials","volume":"105","author":"Yu","year":"2026","journal-title":"Medicine (Baltimore)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"Von Elm","year":"2007","journal-title":"PLoS Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"CD000140","DOI":"10.1002\/14651858.CD000140.pub2","article-title":"Methylxanthine treatment for apnea in preterm infants","volume":"2010","author":"Henderson-Smart","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1414185","DOI":"10.3389\/fped.2024.1414185","article-title":"Association between PER and CRY gene polymorphisms and the response to caffeine citrate treatment in infants with apnea of prematurity","volume":"12","author":"Xie","year":"2024","journal-title":"Front Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpeds.2022.04.028","article-title":"Perinatal inflammatory biomarkers and respiratory disease in preterm infants","volume":"246","author":"Collaco","year":"2022","journal-title":"J Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1923440\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:57:22Z","timestamp":1787723842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1923440\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":25,"alternative-id":["10.3389\/fped.2026.1923440"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1923440","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"article-number":"1923440"}}